Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01535053 · MORE INFO

Limitations, agreements, and source contact

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia · Source last updated 2022-08-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
limitations And Caveats
description
Early closure leading to non-compliance and small numbers of subjects analyzed. Study cannot be considered terminated because some participants are still being examined for follow-up.
point Of Contact
email
lgedeon@gogstats.org
organization
NRG Oncology
phone
716-845-1169
title
Linda Gedeon for Virginia Filiaci, PhD.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
limitations And Caveats
description
Early closure leading to non-compliance and small numbers of subjects analyzed. Study cannot be considered terminated because some participants are still being examined for follow-up.
point Of Contact
email
lgedeon@gogstats.org
organization
NRG Oncology
phone
716-845-1169
title
Linda Gedeon for Virginia Filiaci, PhD.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice